A carregar...

Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer

BACKGROUND: Strict eligibility criteria for patient enrollment in phase III trials raise questions regarding generalization to ineligible patients. We evaluated whether pivotal phase III trials of immune checkpoint blockades (ICBs) represent the overall population of non‐small cell lung cancer (NSCL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Yoo, Shin Hye, Keam, Bhumsuk, Kim, Miso, Kim, Tae Min, Kim, Dong‐Wan, Heo, Dae Seog
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6456815/
https://ncbi.nlm.nih.gov/pubmed/29682899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12641
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!